Basel Medical Group Ltd Ordinary Shares (BMGL)
Automate Your Wheel Strategy on BMGL
With Tiblio's Option Bot, you can configure your own wheel strategy including BMGL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BMGL
- Rev/Share 0.0
- Book/Share 0.0
- PB 0.0
- Debt/Equity 0.5673
- CurrentRatio 2.2578
- ROIC 0.1597
- MktCap 94698526.4826
- FreeCF/Share 0.0
- PFCF 37.8587
- PE 0.0
- Debt/Assets 0.263
- DivYield 0
- ROE 0.3177
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
Published: May 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent volatility in its share price.
Read More
Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
Singapore, May 22, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it has entered into a purchase agreement with a consortium of Bitcoin (BTC) holders for the purchase by the Company of up to 10,000 BTC (with current market value of approximately US$1.0 billion) by issuing of its ordinary shares.
Read More
Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities
Published: May 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Singapore, May 20, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that its subsidiary has been awarded a significant contract worth S$375 million by Pancare Technology International (HK) Limited to supply essential healthcare products in Asia-Pacific over the next five years until October 31, 2029. This milestone underscores the Company's commitment to delivering high-quality medical solutions and strengthening its global presence in the healthcare sector.
Read More
Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move
Published: May 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
Singapore, May 16, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today announced that it has begun exclusive negotiations for a US$1 billion BTC acquisition that will diversify its treasury reserves to a very large extent, while maintaining its core focus on medical services expansion. This is a major strategic financial initiative to strengthen its balance sheet and support its aggressive expansion across Asia's high-growth healthcare markets.
Read More
Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia
Published: April 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
Singapore , April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare provider specializing in diagnostic imaging and outpatient care. The acquisition marks a significant step in Basel Medical Group's strategic expansion in Singapore and the broader Southeast Asian healthcare market.
Read More
About Basel Medical Group Ltd Ordinary Shares (BMGL)
- IPO Date
- Website https://baselmedical.com
- Industry Medical - Healthcare Plans
- CEO Dr. Yen Feng Chhoa M.D.
- Employees 32